Insider Transactions in Q4 2021 at Angiodynamics Inc (ANGO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 31
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-2.06%
|
$27,637
$29.37 P/Share
|
|
Oct 20
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
3,494
-11.69%
|
$94,338
$27.97 P/Share
|
|
Oct 15
2021
|
Scott Centea SVP/GM, VIT |
SELL
Open market or private sale
|
Direct |
12,000
-20.6%
|
$324,000
$27.92 P/Share
|
|
Oct 15
2021
|
Scott Centea SVP/GM, VIT |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+17.08%
|
$192,000
$16.77 P/Share
|
|
Oct 05
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Open market or private sale
|
Direct |
10,748
-25.3%
|
$290,196
$27.15 P/Share
|
|
Oct 05
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
10,748
+20.19%
|
$171,968
$16.59 P/Share
|